Your browser doesn't support javascript.
loading
SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial.
Crabb, Simon; Danson, Sarah J; Catto, James W F; McDowell, Cathy; Lowder, James N; Caddy, Joshua; Dunkley, Denise; Rajaram, Jessica; Ellis, Deborah; Hill, Stephanie; Hathorn, David; Whitehead, Amy; Kalevras, Mihalis; Huddart, Robert; Griffiths, Gareth.
Afiliación
  • Crabb S; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Danson SJ; Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, UK.
  • Catto JWF; Academic Urology Unit, The Medical school, University of Sheffield, Sheffield, UK.
  • McDowell C; Cancer Research UK, London, UK.
  • Lowder JN; Astex Pharmaceuticals, Inc., Pleasanton, CA, USA.
  • Caddy J; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
  • Dunkley D; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK. d.dunkley@soton.ac.uk.
  • Rajaram J; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
  • Ellis D; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
  • Hill S; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
  • Hathorn D; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
  • Whitehead A; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
  • Kalevras M; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
  • Huddart R; The Institute of Cancer Research, Sutton, UK.
  • Griffiths G; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
Trials ; 19(1): 216, 2018 Apr 03.
Article en En | MEDLINE | ID: mdl-29615077
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Azacitidina / Neoplasias de la Vejiga Urinaria / Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Terapia Neoadyuvante / Desoxicitidina Tipo de estudio: Clinical_trials / Guideline Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Azacitidina / Neoplasias de la Vejiga Urinaria / Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Terapia Neoadyuvante / Desoxicitidina Tipo de estudio: Clinical_trials / Guideline Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido